MOONWALK BIOSCIENCES Trademark

Trademark Overview


On Monday, October 2, 2023, a trademark application was filed for MOONWALK BIOSCIENCES with the United States Patent and Trademark Office. The USPTO has given the MOONWALK BIOSCIENCES trademark a serial number of 98206109. The federal status of this trademark filing is FINAL REFUSAL - MAILED as of Tuesday, August 27, 2024. This trademark is owned by Moonwalk Biosciences. The MOONWALK BIOSCIENCES trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Pharmaceutical preparations and substances for the treatment of human, veterinary, and plant diseases and disorders using epigenetic editing technologies, gene therapy, gene editing, and nucleic acids, alone or in combination with small molecules.

Research and development in the field of pharmaceuticals, therapeutics, and biotechnology; Research and development in the field of pharmaceuticals, therapeutics, and biotechnology, namely structural and functional genomics; Conducting research and clinical trials for others relating to pharmaceuticals in the field of human, veterinary, and plant diseases and disorders using epigenetic editing technologies, gene therapy, gene editing, and nucleic acids, alone or in combination with small molecules.
moonwalk biosciences

General Information


Serial Number98206109
Word MarkMOONWALK BIOSCIENCES
Filing DateMonday, October 2, 2023
Status645 - FINAL REFUSAL - MAILED
Status DateTuesday, August 27, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesPharmaceutical preparations and substances for the treatment of human, veterinary, and plant diseases and disorders using epigenetic editing technologies, gene therapy, gene editing, and nucleic acids, alone or in combination with small molecules.
NOT AVAILABLEBIOSCIENCES
Goods and ServicesResearch and development in the field of pharmaceuticals, therapeutics, and biotechnology; Research and development in the field of pharmaceuticals, therapeutics, and biotechnology, namely structural and functional genomics; Conducting research and clinical trials for others relating to pharmaceuticals in the field of human, veterinary, and plant diseases and disorders using epigenetic editing technologies, gene therapy, gene editing, and nucleic acids, alone or in combination with small molecules.

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, October 12, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, October 12, 2023
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameMoonwalk Biosciences
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSouth San Francisco, CA 94080

Trademark Events


Event DateEvent Description
Thursday, October 5, 2023NEW APPLICATION ENTERED
Wednesday, May 22, 2024ASSIGNED TO EXAMINER
Thursday, May 23, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, May 23, 2024NON-FINAL ACTION E-MAILED
Thursday, May 23, 2024NON-FINAL ACTION WRITTEN
Monday, August 19, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, August 19, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, August 19, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, August 27, 2024NOTIFICATION OF FINAL REFUSAL EMAILED
Tuesday, August 27, 2024FINAL REFUSAL WRITTEN
Tuesday, August 27, 2024FINAL REFUSAL E-MAILED
Thursday, October 12, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED